HLF
Herbalife Ltd.
NYSEUSDEQUITY
Consumer Defensive
DELAYED
Neutral
+6/100
Last price
12.61
▲ 0.03 (0.24%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
12.58
Prev close
12.58
Day high
12.85
Day low
12.58
Volume
142.45K
Market cap
$1.31B
P/E (TTM)
8.03
52W range
7.56 – 20.40
Day trading desk
Gap from prior close
0.00%
Prior close 12.58
VWAP
12.74
-1.06% from price
Relative volume
0.07×
Quiet session
Session range
2.15%
12.58 – 12.85
Position in range
11%
Near session low
ATR (14D)
0.38
2.97% of price
Prior day high
12.82
PDH
Prior day low
12.55
PDL
Bid / ask spread
—
Quote not published
Session volume
110.19K
Avg 1.54M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.96%
+2.4%
1M
+1.45%
+0.3%
3M
-2.25%
-5.3%
6M
-16.27%
-30.9%
YTD
-2.17%
-15.8%
1Y
+43.46%
+28.1%
3Y
-7.75%
-89.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HLF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+13.71K
Net buying
Buy transactions
12
205.01K shares
Sell transactions
2
191.30K shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
5.25M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 4, 26 | L'HELIAS SOPHIE Director |
BUY | 1.20K | $13.57K | Direct |
| May 19, 26 | HICKS TROY Chief Operating Officer |
SELL | 48.38K | $619.56K | Direct |
| May 18, 26 | HICKS TROY Chief Operating Officer |
CONVERSION | 83.27K | $775.53K | Direct |
| May 12, 26 | LAMBERTI FRANK Officer |
SELL | 142.92K | $1.93M | Direct |
| May 8, 26 | CLOUD LYNDA B Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | MENDOZA JUAN MIGUEL Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | MILLER PERKINS Director |
STOCK | 13.63K | $0 | Direct |
| May 8, 26 | L'HELIAS SOPHIE Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | MACADRAI RODICA Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | WALSH DESMOND J Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | CARMONA RICHARD H. M.D. Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | MULLIGAN DONAL L Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | LEVITT MICHAEL J Director |
STOCK | 11.88K | $0 | Direct |
| May 8, 26 | OTERO MARIA Director |
STOCK | 11.88K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CARMONA RICHARD H. M.D. |
Director | 83.64K | Stock Award(Grant) |
DEL GENES CELINE |
Director | 55.82K | Stock Award(Grant) |
JOHNSON MICHAEL O |
Officer and Director | 887.41K | Stock Award(Grant) |
L'HELIAS SOPHIE |
Director | 79.88K | Purchase |
MACADRAI RODICA |
Director | 67.44K | Stock Award(Grant) |
MENDOZA JUAN MIGUEL |
Director | 181.88K | Stock Award(Grant) |
MILLER PERKINS |
Director | 50.77K | Stock Award(Grant) |
MULLIGAN DONAL L |
Director | 128.98K | Stock Award(Grant) |
OTERO MARIA |
Director | 95.13K | Stock Award(Grant) |
WALSH DESMOND J |
Director | 261.88K | Stock Award(Grant) |
Fundamentals
Market cap$1.31B
Enterprise value$3.16B
Revenue (TTM)$5.20B
Gross profit$4.04B
EBITDA$625.10M
Net income$164.20M
EPS (TTM)$1.57
Free cash flow$317.90M
Total cash$370.50M
Total debt$2.20B
Book value / share$-4.53
Shares outstanding103.67M
Float84.67M
Short % of float10.04%
Dividend yield0.00%
Beta (5Y)0.79
Valuation & profitability ratios
Trailing P/E8.03
Forward P/E4.10
PEG ratio0.61
Price / sales—
Price / book—
EV / revenue0.61
EV / EBITDA5.05
Gross margin77.70%
Operating margin9.75%
Profit margin3.16%
Return on equity—
Return on assets11.27%
Debt / equity—
Current ratio1.20
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.04B | $4.99B | $5.06B | $5.20B | +0.9% |
| Operating revenue | $5.04B | $4.99B | $5.06B | $5.20B | +0.9% |
| Cost of revenue | $1.11B | $1.10B | $1.19B | $1.17B | +0.9% |
| Gross profit | $3.92B | $3.89B | $3.87B | $4.03B | +0.9% |
| Selling, general & admin | $3.45B | $3.51B | $3.53B | $1.81B | -1.8% |
| Total operating expense | $3.44B | $3.50B | $3.52B | $3.49B | -1.7% |
| Operating income | $481.00M | $385.90M | $356.40M | $545.20M | +24.6% |
| Net interest income | -$205.90M | -$206.00M | -$154.40M | -$133.20M | +0.0% |
| Pre-tax income | $275.10M | $169.40M | $203.00M | $424.80M | +62.4% |
| Tax provision | $47.30M | -$84.90M | $60.80M | $103.50M | +155.7% |
| Net income | $228.30M | $254.30M | $142.20M | $321.30M | -10.2% |
| Net income to common | $228.30M | $254.30M | $142.20M | $321.30M | -10.2% |
| Basic EPS | 2.22 | 2.53 | 1.44 | 3.26 | -12.3% |
| Diluted EPS | 2.20 | 2.50 | 1.42 | 3.23 | -12.0% |
| EBIT | $489.50M | $387.70M | $368.90M | $564.10M | +26.3% |
| EBITDA | $610.70M | $509.10M | $482.20M | $679.50M | +20.0% |
| Basic shares | 102.80M | 100.60M | 99.00M | 98.50M | +2.2% |
| Diluted shares | 103.60M | 101.60M | 100.20M | 99.50M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $353.10M | $415.30M | $575.20M | $508.00M | -15.0% |
| Cash & short-term investments | $353.10M | $415.30M | $575.20M | $508.00M | -15.0% |
| Accounts receivable | $91.90M | $68.90M | $81.20M | $70.60M | +33.4% |
| Inventory | $511.70M | $475.40M | $505.20M | $580.70M | +7.6% |
| Total current assets | $1.14B | $1.14B | $1.40B | $1.36B | +0.1% |
| Property, plant & equipment | $616.00M | $645.90M | $692.30M | $693.40M | -4.6% |
| Goodwill & intangibles | $415.60M | $400.00M | $409.40M | $408.90M | +3.9% |
| Total assets | $2.79B | $2.73B | $2.81B | $2.73B | +2.1% |
| Total current liabilities | $1.01B | $1.23B | $1.28B | $976.60M | -17.7% |
| Current debt | $20.90M | $283.50M | $309.50M | $29.50M | -92.6% |
| Long-term debt | $1.97B | $1.98B | $2.25B | $2.66B | -0.2% |
| Total debt | $2.18B | $2.47B | $2.77B | $2.92B | -11.6% |
| Total liabilities | $3.30B | $3.53B | $3.87B | $4.00B | -6.6% |
| Retained earnings | -$579.70M | -$808.00M | -$1.06B | -$1.20B | +28.3% |
| Shareholder equity | -$515.10M | -$801.10M | -$1.06B | -$1.27B | +35.7% |
| Working capital | $131.80M | -$86.70M | $121.70M | $379.50M | +252.0% |
| Net tangible assets | -$930.70M | -$1.20B | -$1.47B | -$1.67B | +22.5% |
| Shares issued | 103.31M | 101.20M | 99.20M | 97.90M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $227.80M | $254.30M | $142.20M | $321.30M | -10.4% |
| Depreciation & amortisation | $121.20M | $121.40M | $113.30M | $115.40M | -0.2% |
| Stock-based compensation | $44.10M | $50.00M | $48.00M | $44.40M | -11.8% |
| Change in working capital | -$35.50M | $32.50M | $47.70M | -$123.10M | -209.2% |
| Operating cash flow | $333.30M | $285.40M | $357.50M | $352.50M | +16.8% |
| Capital expenditure | -$80.40M | -$122.00M | -$135.00M | -$156.40M | +34.1% |
| Investing cash flow | -$108.70M | -$84.60M | -$134.80M | -$156.20M | -28.5% |
| Financing cash flow | -$295.50M | -$335.30M | -$148.30M | -$264.70M | +11.9% |
| Free cash flow | $252.90M | $163.40M | $222.50M | $196.10M | +54.8% |
| End cash position | $375.30M | $438.10M | $595.50M | $516.30M | -14.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.33B | $1.32B | $1.28B | $1.27B | $1.26B | +0.7% |
| Operating revenue | $1.33B | $1.32B | $1.28B | $1.27B | $1.26B | +0.7% |
| Cost of revenue | $296.30M | $291.10M | $288.30M | $284.20M | $276.90M | +1.8% |
| Gross profit | $1.03B | $1.03B | $994.70M | $989.50M | $982.20M | +0.4% |
| Selling, general & admin | $902.20M | $893.20M | $2.12B | $447.60M | $854.40M | +1.0% |
| Total operating expense | $902.20M | $887.70M | $894.90M | $863.70M | $849.60M | +1.6% |
| Operating income | $128.30M | $138.40M | $99.80M | $125.80M | $132.60M | -7.3% |
| Net interest income | -$37.40M | -$46.80M | -$49.30M | -$51.00M | -$53.60M | +20.1% |
| Pre-tax income | -$3.70M | $91.60M | $50.50M | $74.80M | $79.00M | -104.0% |
| Tax provision | $22.80M | $30.40M | -$34.60M | $31.70M | $29.80M | -25.0% |
| Net income | -$26.30M | $61.20M | $85.60M | $43.20M | $49.30M | -143.0% |
| Net income to common | -$26.30M | $61.20M | $85.60M | $43.20M | $49.30M | -143.0% |
| Basic EPS | -0.25 | 0.60 | 0.83 | 0.42 | 0.48 | -141.7% |
| Diluted EPS | -0.25 | 0.57 | 0.81 | 0.42 | 0.48 | -143.9% |
| EBIT | $36.30M | $141.10M | $101.90M | $127.80M | $134.40M | -74.3% |
| EBITDA | $67.70M | $170.50M | $131.20M | $158.50M | $164.90M | -60.3% |
| Basic shares | 104.50M | 103.80M | 103.50M | 103.30M | 102.70M | +0.7% |
| Diluted shares | 104.50M | 108.40M | 105.00M | 104.00M | 103.30M | -3.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $370.50M | $451.20M | $353.10M | $305.50M | $320.90M | -17.9% |
| Cash & short-term investments | $370.50M | $451.20M | $353.10M | $305.50M | $320.90M | -17.9% |
| Accounts receivable | $115.90M | $106.00M | $91.90M | $97.80M | $96.20M | +9.3% |
| Inventory | $507.70M | $494.60M | $511.70M | $512.50M | $513.10M | +2.6% |
| Total current assets | $1.17B | $1.25B | $1.14B | $1.11B | $1.10B | -6.7% |
| Property, plant & equipment | $579.20M | $598.30M | $616.00M | $628.40M | $647.60M | -3.2% |
| Goodwill & intangibles | $459.10M | $413.70M | $415.60M | $416.70M | $417.50M | +11.0% |
| Total assets | $2.86B | $2.88B | $2.79B | $2.70B | $2.74B | -0.6% |
| Total current liabilities | $973.50M | $1.02B | $1.01B | $999.90M | $1.09B | -4.8% |
| Current debt | $12.00M | $9.20M | $20.90M | $20.70M | $168.00M | +30.4% |
| Long-term debt | $2.00B | $1.98B | $1.97B | $2.00B | $1.97B | +1.1% |
| Total debt | $2.20B | $2.18B | $2.18B | $2.21B | $2.35B | +1.0% |
| Total liabilities | $3.32B | $3.31B | $3.30B | $3.30B | $3.39B | +0.5% |
| Retained earnings | -$544.10M | -$517.80M | -$579.70M | -$665.10M | -$708.30M | -5.1% |
| Shareholder equity | -$474.50M | -$441.50M | -$515.10M | -$612.00M | -$660.50M | -7.5% |
| Working capital | $195.30M | $230.00M | $131.80M | $106.30M | $8.60M | -15.1% |
| Net tangible assets | -$933.60M | -$855.20M | -$930.70M | -$1.03B | -$1.08B | -9.2% |
| Shares issued | 104.80M | 103.41M | 103.31M | 103.20M | 103.10M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$26.50M | $61.20M | $85.10M | $43.10M | $49.20M | -143.3% |
| Depreciation & amortisation | $31.40M | $29.40M | $29.30M | $30.70M | $30.50M | +6.8% |
| Stock-based compensation | $10.10M | $10.60M | $10.90M | $11.20M | $10.40M | -4.7% |
| Change in working capital | -$77.20M | $4.10M | $36.70M | $15.90M | $6.80M | -1,982.9% |
| Operating cash flow | $32.90M | $113.80M | $98.30M | $138.80M | $96.00M | -71.1% |
| Capital expenditure | -$11.30M | -$10.90M | -$18.50M | -$20.80M | -$22.80M | -3.7% |
| Investing cash flow | -$21.60M | -$11.20M | -$18.70M | -$20.60M | -$50.60M | -92.9% |
| Share buybacks | -$9.30M | -$700.00K | -$100.00K | -$1.30M | -$4.60M | -1,228.6% |
| Financing cash flow | -$82.70M | $2.00M | -$32.70M | -$130.40M | -$60.20M | -4,235.0% |
| Free cash flow | $21.60M | $102.90M | $79.80M | $118.00M | $73.20M | -79.0% |
| End cash position | $393.40M | $473.00M | $375.30M | $328.00M | $343.60M | -16.8% |
Options analytics
Put / call volume
1.03
Put-heavy session
Put / call open interest
0.09
Positioning, not flow
Max pain
2.00
-84.1% from spot
ATM implied vol
72.3%
Nearest strike to spot
Skew (10% OTM)
+119.1%
Puts bid over calls
Call volume
213
Contracts, this expiry
Put volume
219
Contracts, this expiry
Heaviest call OI
2.00
275 contracts
Heaviest put OI
17.50
85 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.54 | 0.51 | -4.9% |
| Mar 2026 | 0.61 | 0.64 | +5.4% |
| Dec 2025 | 0.48 | 0.45 | -5.6% |
| Sep 2025 | 0.46 | 0.50 | +8.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.62 | 2 | $1.31B | +2.8% |
| Next quarter | 0.61 | 2 | $1.31B | +1.8% |
| Current year | 2.37 | 2 | $5.26B | +4.4% |
| Next year | 3.08 | 2 | $5.39B | +2.5% |
Analyst targets & ownership
Mean target$17.00
High target$25.00
Low target$9.00
Implied upside34.81%
Analyst count3
ConsensusNONE
Strong buy / Buy1 / 2
Hold0
Sell / Strong sell0 / 1
Held by insiders5.01%
Held by institutions101.18%
Institutions holding333
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.45
+1.32% from price
SMA 20
12.21
+3.24% from price
SMA 50
12.23
+3.09% from price
SMA 100
12.25
+2.97% from price
SMA 200
14.04
-10.18% from price
EMA 12
12.40
+1.73% from price
EMA 26
12.30
+2.55% from price
EMA 50
12.32
+2.36% from price
RSI (14)
56.1
Neutral
MACD (12,26,9)
0.10
Hist 0.05
ATR (14)
0.38
2.97% of price
Realised vol 30D
48.7%
Annualised
Bollinger upper
12.79
20, 2σ
Bollinger lower
11.64
20, 2σ
50 / 200 cross
Death
12.23 vs 14.04
Trend bias
Below 200
-10.18%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.15
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
48.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-44.9%
Peak to trough
Max drawdown 5Y
-89.2%
Peak to trough
ATR 14
0.38
2.97% of price
Beta (reported)
0.79
5Y monthly, from filing
Short interest
Shares short
9.02M
Prior 9.31M
Change vs prior
-3.1%
Shorts covering
% of float
10.04%
Elevated
% of shares out
8.61%
Against total outstanding
Days to cover
5.3
Crowded exit
Float
84.67M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Apr 28, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Mar 30, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Feb 19, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jan 8, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Jan 6, 26 | Maxim Group | INITIATED | — | Buy |
| Dec 12, 25 | Citigroup | MAINTAINED | Buy | Buy |
| Nov 26, 25 | Mizuho | MAINTAINED | Neutral | Neutral |
| Nov 26, 25 | Argus Research | UPGRADE | Hold | Buy |
| Jul 28, 25 | Mizuho | MAINTAINED | Neutral | Neutral |
| May 1, 25 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 21, 25 | DA Davidson | UPGRADE | Neutral | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield1.59%
Payout ratio0.00%
Ex-dividend dateFeb 28, 2014
Next pay dateMar 18, 2014
Last split2:1
Split dateMay 15, 2018
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-31
Corporate Changes & Voting Matters
8-K · 2026-08-05
Periodic Financial Reports
10-Q · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-01
Corporate Changes & Voting Matters
8-K · 2026-04-16
Corporate Changes & Voting Matters
8-K · 2026-04-14
Proxy Statements
DEFA14A · 2026-03-17
Corporate Changes & Voting Matters
8-K · 2026-02-18
Headlines
Herbalife to Participate in 1 on 1 Meetings at Maxim Growth Summit on October 14
Business Wire · 2d ago
Deepa Malik Shares Powerful Lessons on Resilience, Reinvention and Self Belief on Herbalife India's Live Your Best Life, Unscripted
PR Newswire · 6d ago
Herbalife to Announce Third Quarter 2026 Results on November 2
Business Wire · 6d ago
2 Safe-and-Steady Stocks to Target This Week and 1 We Brush Off
StockStory · 7d ago
Herbalife India Joins Hands with Indian Olympic Association as Official Nutrition Partner for the Indian Contingent at Asian Games 2026
PR Newswire · 9d ago
Should Value Investors Buy Herbalife Ltd (HLF) Stock?
Zacks · 13d ago
Herbalife (HLF) Approves $250 Million Buyback, Is The 28% Undervaluation Real?
Simply Wall St. · 14d ago
Best Health & Fitness Stocks to Buy as Wellness Demand Grows
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.